COX-2 inhibitor protection against skin cancer questionable

被引：0

|

作者：

Klein, Friederike

机构：

来源：

AKTUELLE DERMATOLOGIE | 2023年 / 49卷 / 06期

关键词：

D O I：

10.1055/a-2054-7374

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

收藏

页码：249 / 249

页数：1

相关论文

共 50 条

[41] On the safety of nimesulide, a preferential COX-2 inhibitor
Kulkarni, SK
CURRENT SCIENCE, 2002, 83 (12): : 1442 - 1443
[42] Rofecoxib -: Vioxx® -: Antiarthritic -: COX-2 inhibitor
不详
DRUGS OF THE FUTURE, 2000, 25 (12) : 1325 - 1328
[43] Rofecoxib: A selective and effective COX-2 inhibitor
不详
Drugs & Therapy Perspectives, 2002, 18 (2) : 1 - 3
[44] National patterns of COX-2 inhibitor use
Steinman, M
Covinsky, K
JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 : 204 - 204
[45] Short Synthesis of COX-2 Inhibitor Inotilone
Al-Busafi, Saleh
Al-Belushi, Muna
Al-Muqbali, Khalid
SYNTHETIC COMMUNICATIONS, 2010, 40 (07) : 1088 - 1092
[46] JTE-522 - COX-2 inhibitor
不详
DRUGS OF THE FUTURE, 2001, 26 (06) : 598 - 599
[47] Etodolac: An overview of a selective COX-2 inhibitor
Jones R.A.
InflammoPharmacology, 1999, 7 (3) : 269 - 275
[48] NS-398 - COX-2 inhibitor
不详
DRUGS OF THE FUTURE, 2000, 25 (07) : 759 - 760
[49] NSAIDs: gastroprotection or selective COX-2 inhibitor?
Dickman, A
Ellershaw, J
PALLIATIVE MEDICINE, 2004, 18 (04) : 275 - 286
[50] Rofecoxib -: Vioxx® -: Antiarthritic -: COX-2 inhibitor
不详
DRUGS OF THE FUTURE, 2001, 26 (12) : 1213 - 1215

← 1 2 3 4 5 →